Xeris Pharmaceuticals | XERS - Sales Revenues

Stock Price
5.58
Daily Change
0.15 2.76%
Monthly
-15.58%
Yearly
2.76%
Q1 Forecast
5.30

Xeris Pharmaceuticals reported $85.81M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Celltrion KRW 1.33T 0 Mar/2026
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pacira USD 196.87M 17.35M Dec/2025
Perrigo USD 1.11B 70M Dec/2025
Pharma Mar EUR 90.2M 54.5M Dec/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Supernus Pharmaceuticals USD 211.6M 19.5M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025